{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:18:55Z","timestamp":1790191135354,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T00:00:00Z","timestamp":1559779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T00:00:00Z","timestamp":1559779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007771","name":"\u015al\u0105ski Uniwersytet Medyczny","doi-asserted-by":"publisher","award":["KNW-2-005-N\/7\/K"],"award-info":[{"award-number":["KNW-2-005-N\/7\/K"]}],"id":[{"id":"10.13039\/100007771","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007771","name":"\u015al\u0105ski Uniwersytet Medyczny","doi-asserted-by":"publisher","award":["KNW-1-034\/K\/7\/O"],"award-info":[{"award-number":["KNW-1-034\/K\/7\/O"]}],"id":[{"id":"10.13039\/100007771","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007771","name":"\u015al\u0105ski Uniwersytet Medyczny","doi-asserted-by":"publisher","award":["KNW-2-015\/N\/8\/K"],"award-info":[{"award-number":["KNW-2-015\/N\/8\/K"]}],"id":[{"id":"10.13039\/100007771","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s00210-019-01668-5","type":"journal-article","created":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T22:02:26Z","timestamp":1559858546000},"page":"1257-1264","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Antimelanoma activity of perphenazine and prochlorperazine in human COLO829 and C32 cell lines"],"prefix":"10.1007","volume":"392","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7523-7737","authenticated-orcid":false,"given":"Micha\u0142","family":"Otr\u0119ba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Pajor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared D.","family":"Warncke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,6]]},"reference":[{"key":"1668_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/2155-9929.1000129","volume":"3","author":"M Agnarsd\u00f3ttir","year":"2012","unstructured":"Agnarsd\u00f3ttir M, Ponten F, Garmo H, Wagenius G, Mucci L, Magnusson K, Holmberg L, Eaker-F\u00e4lt S (2012) MITF expression in cutaneous malignant melanoma. J Mol Biomark Diagn 3:1\u20137","journal-title":"J Mol Biomark Diagn"},{"key":"1668_CR2","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1186\/1471-2407-14-853","volume":"14","author":"JP Alao","year":"2014","unstructured":"Alao JP, Michlikova S, Din\u00e9r P, Gr\u00f8tli M, Sunnerhagen P (2014) Selective inhibition of RET mediated cell proliferation in vitro by the kinase inhibitor SPP86. BMC Cancer 14:853","journal-title":"BMC Cancer"},{"key":"1668_CR3","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s40257-013-0025-9","volume":"14","author":"M Batus","year":"2013","unstructured":"Batus M, Waheed S, Ruby C, Petersen L, Bines SD, Kaufman HL (2013) Optimal management of metastatic melanoma: current strategies and future directions. Am J Clin Dermatol 14:179\u2013194","journal-title":"Am J Clin Dermatol"},{"key":"1668_CR4","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.2174\/1568026616666160216160112","volume":"16","author":"E Buitrago","year":"2016","unstructured":"Buitrago E, Hardr\u00e9 R, Haudecoeur R, Jamet H, Belle C, Boumendjel A, Bubacco L, R\u00e9glier M (2016) Are human tyrosinase and related proteins suitable targets for melanoma therapy? Curr Top Med Chem 16:3033\u20133047","journal-title":"Curr Top Med Chem"},{"key":"1668_CR5","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.bcp.2013.11.008","volume":"87","author":"HH Cao","year":"2014","unstructured":"Cao HH, Tse AKW, Kwan HY, Yu H, Cheng CY, Su T, Fong WF, Yu Z (2014) Quercetin exerts anti-melanoma activities and inhibits STAT3 signaling. Biochem Pharmacol 87:424\u2013434","journal-title":"Biochem Pharmacol"},{"key":"1668_CR6","doi-asserted-by":"publisher","first-page":"3426","DOI":"10.1101\/gad.406406","volume":"20","author":"S Carreira","year":"2006","unstructured":"Carreira S, Goodall J, Denat L, Rodriguez M, Nuciforo P, Hoek KS, Testori A, Larue L, Goding CR (2006) Mitf regulation of Dia1 controls melanoma proliferation and invasiveness. Genes Dev 20:3426\u20133439","journal-title":"Genes Dev"},{"key":"1668_CR7","first-page":"1164","volume":"16","author":"A Chiaravalloti","year":"2017","unstructured":"Chiaravalloti A, Banki A (2017) An elusive amelanotic melanoma and review of dermoscopic findings. J Drugs Dermatol 16:1164\u20131165","journal-title":"J Drugs Dermatol"},{"key":"1668_CR8","first-page":"396","volume":"104","author":"HH Drobek","year":"2017","unstructured":"Drobek HH, Bergler-Czop BS, Mizio\u0142ek B (2017) From chemotherapy to oncoviruses \u2013 modern methods of treatment in metastatic melanoma. Dermatol Rev\/Przegl Dermatol 104:396\u2013410","journal-title":"Dermatol Rev\/Przegl Dermatol"},{"key":"1668_CR9","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ebiom.2017.01.013","volume":"16","author":"ME Fane","year":"2017","unstructured":"Fane ME, Chhabra Y, Hollingsworth DEJ, Simmons JL, Spoerri L, Oh TG, Chauhan J, Chin T, Harris L, Harvey TJ, Muscat GEO, Goding CR, Sturm RA, Haass NK, Boyle GM, Piper M, Smith AG (2017) NFIB mediates BRN2 driven melanoma cell migration and invasion through regulation of EZH2 and MITF. EBioMedicine. 16:63\u201375","journal-title":"EBioMedicine."},{"key":"1668_CR10","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ejca.2016.05.005","volume":"63","author":"C Garbe","year":"2016","unstructured":"Garbe C, Peris K, Hauschild A, Saiag P, Middleton M, Bastholt L, Grob JJ, Malvehy J, Newton-Bishop J, Stratigos AJ, Pehamberger H, Eggermont AM, European Dermatology Forum (EDF); European Association of Dermato-Oncology (EADO); European Organisation for Research and Treatment of Cancer (EORTC) (2016) Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline \u2013 update 2016. Eur J Cancer 63:201\u2013217","journal-title":"Eur J Cancer"},{"key":"1668_CR11","first-page":"107","volume":"15","author":"I Gil-Ad","year":"2006","unstructured":"Gil-Ad I, Shtaif B, Levkovitz Y, Nordenberg J, Taler M, Korov I, Weizman A (2006) Phenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growth. Oncol Rep 15:107\u2013112","journal-title":"Oncol Rep"},{"key":"1668_CR12","first-page":"341","volume":"3","author":"V Girly","year":"2014","unstructured":"Girly V, Baldwin MV, Jini J, Meena C, Bhat AR, Kumar KK (2014) A review on biological activities of thiazine derivatives. Int P Pharm Chem Biol Sci 3:341\u2013348","journal-title":"Int P Pharm Chem Biol Sci"},{"key":"1668_CR13","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ejca.2016.01.011","volume":"60","author":"M Harries","year":"2016","unstructured":"Harries M, Malvehy J, Lebbe C, Heron L, Amelio J, Szabo Z, Schadendorf D (2016) Treatment patterns of advanced malignant melanoma (stage III-IV) - a review of current standards in Europe. Eur J Cancer 60:179\u2013189","journal-title":"Eur J Cancer"},{"key":"1668_CR14","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s00018-014-1791-0","volume":"72","author":"ML Hartman","year":"2015","unstructured":"Hartman ML, Czyz M (2015) MITF in melanoma: mechanisms behind its expression and activity. Cell Mol Life Sci 72:1249\u20131260","journal-title":"Cell Mol Life Sci"},{"key":"1668_CR15","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.2174\/1871520618666171213143455","volume":"18","author":"SH Hashemi-Shahri","year":"2018","unstructured":"Hashemi-Shahri SH, Golshan A, Mohajeri SA, Baharara J, Amini E, Salek F, Sahebkar A, Tayarani-Najaran Z (2018) ROS-scavenging and anti-tyrosinase properties of crocetin on B16F10 murine melanoma cells. Anti Cancer Agents Med Chem 18:1064\u20131069","journal-title":"Anti Cancer Agents Med Chem"},{"key":"1668_CR16","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/S1734-1140(12)70726-0","volume":"64","author":"A Jaszczyszyn","year":"2012","unstructured":"Jaszczyszyn A, G\u0105siorowski K, \u015awi\u0105tek P, Malinka W, Cie\u015blik-Boczula K, Petrus J, Czarnik-Matusewicz B (2012) Chemical structure of phenothiazines and their biological activity. Pharmacol Rep 64:16\u201323","journal-title":"Pharmacol Rep"},{"key":"1668_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3791\/51046","volume":"88","author":"CR Justus","year":"2014","unstructured":"Justus CR, Leffler N, Ruiz-Echevarria M, Yang LV (2014) In vitro cell migration and invasion assays. J Vis Exp 88:1\u20138. \n                    https:\/\/doi.org\/10.3791\/51046","journal-title":"J Vis Exp"},{"key":"1668_CR18","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/labinvest.2017.9","volume":"97","author":"A Kawakami","year":"2017","unstructured":"Kawakami A, Fisher DE (2017) The master role of microphthalmia-associated transcription factor in melanocyte and melanoma biology. Lab Investig 97:649\u2013656","journal-title":"Lab Investig"},{"key":"1668_CR19","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/bjc.2017.200","volume":"117","author":"OF Kuzu","year":"2017","unstructured":"Kuzu OF, Gowda R, Noory MA, Robertson GP (2017) Modulating cancer cell survival by targeting intracellular cholesterol transport. Br J Cancer 117:513\u2013524","journal-title":"Br J Cancer"},{"key":"1668_CR20","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.3390\/ijms16011495","volume":"16","author":"SM Lee","year":"2015","unstructured":"Lee SM, Chen YS, Lin CC, Chen KH (2015) Hair dyes resorcinol and lawsone reduce production of melanin in melanoma cells by tyrosinase activity inhibition and decreasing tyrosinase and microphthalmia-associated transcription factor (MITF) expression. Int J Mol Sci 16:1495\u20131508","journal-title":"Int J Mol Sci"},{"key":"1668_CR21","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3322\/caac.21349","volume":"66","author":"KD Miller","year":"2016","unstructured":"Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, Stein KD, Alteri R, Jemal A (2016) Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin 66:271\u2013289","journal-title":"CA Cancer J Clin"},{"key":"1668_CR22","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.2174\/138945006778226624","volume":"7","author":"N Motohashi","year":"2006","unstructured":"Motohashi N, Kawase M, Satoh K, Sakagami H (2006) Cytotoxic potential of phenothiazines. Curr Drug Targets 7:1055\u20131066","journal-title":"Curr Drug Targets"},{"key":"1668_CR23","unstructured":"National Cancer Institute (NCI), NCI-supported clinical trials \n                    https:\/\/www.cancer.gov\/\n                    \n                  . Accessed 19 Apr 2019"},{"key":"1668_CR24","first-page":"19","volume":"73","author":"M Otr\u0119ba","year":"2018","unstructured":"Otr\u0119ba M, Buszman E (2018) Perphenazine and prochlorperazine induce concentration-dependent loss in human glioblastoma cells viability. Pharmazie. 73:19\u201321","journal-title":"Pharmazie."},{"key":"1668_CR25","first-page":"33","volume":"66","author":"M Otr\u0119ba","year":"2012","unstructured":"Otr\u0119ba M, Rok J, Buszman E, Wrze\u015bniok D (2012) Regulation of melanogenesis: the role of cAMP and MITF. Postepy Hig Med Dosw 66:33\u201340","journal-title":"Postepy Hig Med Dosw"},{"key":"1668_CR26","first-page":"903","volume":"73","author":"M Otr\u0119ba","year":"2016","unstructured":"Otr\u0119ba M, Wrze\u015bniok D, Beberok A, Rok J, Buszman E (2016) Fluphenazine and perphenazine impact on melanogenesis and antioxidant enzymes activity in normal human melanocytes. Acta Pol Pharm Drug Res 73:903\u2013911","journal-title":"Acta Pol Pharm Drug Res"},{"key":"1668_CR27","first-page":"171","volume":"72","author":"M Otr\u0119ba","year":"2017","unstructured":"Otr\u0119ba M, Wrze\u015bniok D, Rok J, Beberok A, Buszman E (2017) Prochlorperazine interaction with melanin and melanocytes. Pharmazie. 72:171\u2013176","journal-title":"Pharmazie."},{"key":"1668_CR28","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/icb.1986.56","volume":"64","author":"PG Parsons","year":"1986","unstructured":"Parsons PG, Allen BJ (1986) Accumulation of chlorpromazine and thiouracil by human melanoma cells in culture. Aust J Exp Biol Med Sci 64:517\u2013526","journal-title":"Aust J Exp Biol Med Sci"},{"key":"1668_CR29","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.critrevonc.2017.05.001","volume":"115","author":"J Pitcovski","year":"2017","unstructured":"Pitcovski J, Shahar E, Aizenshtein E, Gorodetsky R (2017) Melanoma antigens and related immunological markers. Crit Rev Oncol Hematol 115:36\u201349","journal-title":"Crit Rev Oncol Hematol"},{"key":"1668_CR30","first-page":"60","volume":"66","author":"J Rok","year":"2012","unstructured":"Rok J, Otr\u0119ba M, Buszman E, Wrze\u015bniok D (2012) Melanin \u2013 from melanocyte to keratinocyte, that is how melanin is transported within the skin. Ann Acad Med Siles 66:60\u201366","journal-title":"Ann Acad Med Siles"},{"key":"1668_CR31","first-page":"447","volume":"58","author":"M Schulz","year":"2003","unstructured":"Schulz M, Schmoldt A (2003) Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics. Pharmazie. 58:447\u2013474","journal-title":"Pharmazie."},{"key":"1668_CR32","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","volume":"68","author":"RL Siegel","year":"2018","unstructured":"Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin 68:7\u201330","journal-title":"CA Cancer J Clin"},{"key":"1668_CR33","doi-asserted-by":"publisher","first-page":"10909","DOI":"10.1038\/s41598-017-11366-y","volume":"7","author":"JL Simmons","year":"2017","unstructured":"Simmons JL, Pierce CJ, Al-Ejeh F, Boyle GM (2017) MITF and BRN2 contribute to metastatic growth after dissemination of melanoma. Sci Rep 7:10909. \n                    https:\/\/doi.org\/10.1038\/s41598-017-11366-y","journal-title":"Sci Rep"},{"key":"1668_CR34","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ejphar.2010.08.045","volume":"648","author":"G Sudeshna","year":"2010","unstructured":"Sudeshna G, Parimal K (2010) Multiple non-psychiatric effects of phenothiazines: a review. Eur J Pharmacol 648:6\u201314","journal-title":"Eur J Pharmacol"},{"key":"1668_CR35","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1001\/jamadermatol.2014.1348","volume":"150","author":"NE Thomas","year":"2014","unstructured":"Thomas NE, Kricker A, Waxweiler WT, Dillon PM, Busam KJ, From L, Groben PA, Armstrong BK, Anton-Culver H, Gruber SB, Marrett LD, Gallagher RP, Zanetti R, Rosso S, Dwyer T, Venn A, Kanetsky PA, Orlow I, Paine S, Ollila DW, Reiner AS, Luo L, Hao H, Frank JS, Begg CB, Berwick M (2014) Comparison of clinicopathologic features and survival of histopathologically amelanotic and pigmented melanomas a population-based study. JAMA Dermatol 150:1306\u20131314","journal-title":"JAMA Dermatol"},{"key":"1668_CR36","doi-asserted-by":"publisher","first-page":"162","DOI":"10.4172\/2168-9431.1000162","volume":"6","author":"J Vachtenheim","year":"2017","unstructured":"Vachtenheim J (2017) The many roles of MITF in melanoma. Single Cell Biol 6:162. \n                    https:\/\/doi.org\/10.4172\/2168-9431.1000162","journal-title":"Single Cell Biol"},{"key":"1668_CR37","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1111\/jcmm.13506","volume":"22","author":"K Vl\u010dkov\u00e1","year":"2018","unstructured":"Vl\u010dkov\u00e1 K, Vachtenheim J, R\u00e9da J, Hor\u00e1k P, Ondru\u0161ov\u00e1 L (2018) Inducibly decreased MITF levels do not affect proliferation and phenotype switching but reduce differentiation of melanoma cells. J Cell Mol Med 22:2240\u20132251. \n                    https:\/\/doi.org\/10.1111\/jcmm.13506","journal-title":"J Cell Mol Med"},{"key":"1668_CR38","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/pcmr.12370","volume":"28","author":"C Wellbrock","year":"2015","unstructured":"Wellbrock C, Arozarena I (2015) Microphthalmia-associated transcription factor in melanoma development and MAP-kinase pathway targeted therapy. Pigment Cell Melanoma Res 28:390\u2013406","journal-title":"Pigment Cell Melanoma Res"},{"key":"1668_CR39","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0379-0738(01)00483-2","volume":"122","author":"CL Winek","year":"2001","unstructured":"Winek CL, Wahba WW, Winek CL Jr, Balzer TW (2001) Drug and chemical blood-level data 2001. Forensic Sci Int 122:107\u2013123","journal-title":"Forensic Sci Int"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-019-01668-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-019-01668-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-019-01668-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T23:30:11Z","timestamp":1591313411000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-019-01668-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,6]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["1668"],"URL":"https:\/\/doi.org\/10.1007\/s00210-019-01668-5","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,6]]},"assertion":[{"value":"7 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}